CXO Talks: Nick Kadysh the Founding CEO & President at PharmAla Biotech, in an Illuminating Dialogue Exchange with PharmaShots
In the second reprise of our Complimentary Exclusive Video Interview, we had the pleasure to speak with Nick Kadysh, the Founding CEO and President of PharmAla Biotech. Our complimentary exclusive video interview is an initiative to voice the global biopharma leaders by offering them a platform to shed light on the developments in the healthcare and medical sectors.
Nick highlights PharmAla’s exciting journey to becoming an MDMA-focused company. Nick talks about PharmAla’s recent joint venture with Vitura Health to form Cortexa. The joint venture aims to make Cortexa, a leading MDMA and Psilocybin supplier in the Australian market.
Nick opens up about the recently launched Prescriber’s portal for medical professionals bestowed with prescribing power for a deeper understanding of MDMA and its effects. Nick also talks about the recent patent allowance for ALA-002 by the USPTO. While addressing the stigmas attached to psychedelic and substance abuse, Nick talks about the company’s pipeline, including ALA-002 and APA-001.
Image Source: Canva
About the Author:
Nick Kadysh
With over a decade of experience as a Public Affairs and Regulatory expert, Nick Kadysh is the founder and CEO of PharmAla Biotech, a Toronto-based Life Sciences company focused on the manufacturing and development of MDMA and MDXX-class molecules.
Prior to launching PharmAla in 2020, Nick led government relations and regulatory departments for several large corporations, including acting as Head of Corporate Affairs for JUUL Labs, as Government Affairs & Public Policy Leader for General Electric Canada, and as Director of Public Affairs for Red Bull Canada.
Nick gained a deep understanding of government as a campaign and legislative staff member in multiple levels of government prior to joining the corporate sector, most recently directing the Outreach department of the Office of the Leader of the Opposition at Queen’s Park in Toronto. He has also worked as a policy advisor at the Parliament of Canada.
Nick is trilingual (English, French & Russian) and is a graduate of Queen’s University. He lives in East Toronto with his wife, Olga, and two daughters, Milena and Sasha. He is active in non-profit and community initiatives in Toronto, including fundraising for Toronto East General Hospital and as a member of the board for Yonge-Dundas Square.
Related Post: Spotlight: David A. Dodd, Chairman President and CEO of GeoVax Labs Inc. in a riveting conversation with PharmaShots
Tags
Himanshu brings over 12 years of Pharma, Life Sciences, and Biotech expertise to Pharmashots. A self-proclaimed "Pharma Geek," his passion for the industry shines through. His career path blends hands-on lab research with high-level consulting at firms like PwC-Health Industries and Novartis. Himanshu holds a degree in Immunology from the University of Leeds, and boasts further credentials from IIM Lucknow and the London School of Economics. Connect with Himanshu to dive deeper into the dynamic world of pharmaceuticals and life sciences.
